Thiel-backed psychedelics startup Atai valued at $3.19 billion in Nasdaq debut
(Reuters) -Shares of Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, surged 40% in their U.S. stock market debut on Friday, [...]
Home »
German psychedelic startup Atai targets valuation of $2.3 billion in U.S. IPO
(Reuters) – Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, said on Friday it was looking to raise as much as [...]